Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. - Wikidata - wikimedia - TriplyDB

Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens.

Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens.

http://www.wikidata.org/entity/Q41848500

about

Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance Murine models to study Clostridium difficile infection and transmission Characterization of the Dynamic Germination of Individual Clostridium difficile Spores Using Raman Spectroscopy and Differential Interference Contrast Microscopy.Structural and functional analysis of the CspB protease required for Clostridium spore germination SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins Functional analysis of SleC from Clostridium difficile: an essential lytic transglycosylase involved in spore germination Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells Determination of the in vitro Sporulation Frequency of Clostridium difficile.Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice Global analysis of the sporulation pathway of Clostridium difficile.Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile.Fecal microbiota transplantation for management of Clostridium difficile infection.SpoIIID-mediated regulation of σK function during Clostridium difficile sporulation.High-throughput analysis of gene essentiality and sporulation in Clostridium difficile The post-translational modification of the Clostridium difficile flagellin affects motility, cell surface properties and virulence.A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.Models for the study of Clostridium difficile infection.Clostridium difficile colitis: pathogenesis and host defence Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Functional characterization of Clostridium difficile spore coat proteins.Characterization of Clostridium difficile Spores Lacking Either SpoVAC or Dipicolinic Acid Synthetase.Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.Clostridium difficile infection in the twenty-first century.The role played by contaminated surfaces in the transmission of nosocomial pathogens.Clostridium difficile spores: a major threat to the hospital environment.Best practice in healthcare environment decontamination.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.High-touch surfaces: microbial neighbours at hand.Revisiting the role of Csp family proteins in regulating Clostridium difficile spore germination.Octahedron Iron Oxide Nanocrystals Prohibited Clostridium difficile Spore Germination and Attenuated Local and Systemic Inflammation.Clostridium difficile surface proteins are anchored to the cell wall using CWB2 motifs that recognise the anionic polymer PSII.The Clostridium difficile spo0A gene is a persistence and transmission factor.Inducible Expression of spo0A as a Universal Tool for Studying Sporulation in Clostridium difficile.Transmission of Clostridium difficile spores in isolation room environments and through hospital beds.A simple decontamination approach using hydrogen peroxide vapour for Bacillus anthracis spore inactivation.An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms.

P2860

Q26771995-D69C38E7-1449-488F-905A-7EEB1DBE2203 Q26859965-FEF4AF75-5DA1-4F81-A42A-A191839B448C Q27322451-66EEE867-7B84-495F-BE4E-6AA0C4D8F25F Q27676376-D7BB5609-CD9E-4936-8296-27BFD7E627D9 Q28485783-A530D821-6DB2-4274-93F2-BA0DD5EACB27 Q28485786-328BFD14-EE83-49AC-BB85-35D9599753A1 Q28821061-B7C3CE92-9814-4BE8-8EC5-2C8961323C09 Q33687895-D29AC4C4-E882-49EF-B155-DA6D12C0D3D2 Q33900157-0F9943F5-7931-41B2-9A98-9A2DDEAA9377 Q34062256-D5904203-97EF-4DC1-9E28-2C12B8A02212 Q34297673-15202532-6BAE-4DFA-A69F-C425C43D0D57 Q34468946-ECCADAFF-B71F-4D88-A7E6-8F26A0C28635 Q34945584-412A3D56-0841-4CD2-9399-0F2F0264E4B2 Q35008836-8EF08190-97C2-4BD2-B673-54294A5B8AA7 Q35152973-8F862FC5-1DCB-4F0C-8365-F36BD75437AA Q35226416-BFCDB049-7E3F-4552-8008-F37017576CCE Q35567539-09094C47-B670-4424-9E32-203ADE2FCFFA Q35636284-FDDD8590-996B-4BC9-92BD-43EC58CDCA44 Q35677616-D70FE9B1-E8B0-4B34-B2E2-39075B3A9C54 Q35773934-028082B9-B013-45B5-8C79-566461703ABA Q36019356-D85ACBE7-4B5C-42D6-B8CC-B3F3BA0594FE Q36116428-67B22F5C-61AF-49B1-892B-EE26D4CA1E8D Q36190012-9BDCEFB8-9646-4D71-857A-99E555E90CC9 Q36760571-263B74FE-5C26-43E6-A7DF-CDB9D3976169 Q37122501-840A884F-AF1A-470A-807F-4899E54DE22B Q37197521-5EC0371C-A7CF-4F2F-8DFE-CDC0F7CE2EAF Q37289567-14A9D80E-645D-42D1-93C8-BE843746D90C Q37888374-9D81EBE7-29ED-4461-A947-67439B2C6972 Q38210321-C32F9481-8280-45CB-9EEC-9515846BA9C8 Q38233802-A6D8C6A0-D5B8-44B3-B437-B22FE227767C Q38794312-25FCB698-437B-430A-B7F3-8E85C14443B9 Q39396781-9506A2E2-8C3A-450F-B0D6-758AAB600909 Q40065922-A11626A2-A9E0-4F72-B282-8966688B8053 Q40091985-C51F0C4E-B2E5-4835-AD63-98BB0D6E1058 Q41504953-9D705195-A625-411D-97E5-BD7A5303AB2F Q41817325-CD3111D9-5B80-4D8B-8F28-02BB69FE6232 Q41972804-4E647ECF-FD83-4B12-8417-D4D89D727952 Q42230696-4FD75062-A97E-465E-805D-14C5ADC31145 Q48282950-79F49E40-5735-4880-9948-10C51F6B38AB Q48487882-E98753AF-1D95-44EE-AAEF-72814E8E8FCA

P2860

Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens.

http://www.wikidata.org/entity/Q41848500

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Use of purified Clostridium di ...... th care disinfection regimens.

@en

type

label

Use of purified Clostridium di ...... th care disinfection regimens.

@en

prefLabel

Use of purified Clostridium di ...... th care disinfection regimens.

@en

P1433

Q41848500-55C5D965-40D6-4C30-A658-E686A22C0F10

P1476

Q41848500-52F60005-63D3-469B-967B-6F8CA47FF571

P2093

Q41848500-01C8CE2E-A875-4387-8315-21B9300243AC

Q41848500-2F366E5D-208E-407A-9320-D15672E17F73

Q41848500-32C4737F-B1B1-4F2C-8A9E-65DA92563E8A

Q41848500-33C9689A-B4AD-451C-8708-5CEC5B981681

Q41848500-3F2B31D2-53E0-469D-84AC-8429D5C7BA48

Q41848500-69FED27D-AEA2-4173-A6E9-5111E55279B7

Q41848500-6FD7DF19-44EC-4DA9-B138-69580B1315E7

Q41848500-ABE590DA-9844-4705-9F95-413BCDD88547

Q41848500-AE3319CB-96D6-4D73-AA01-228FBBC2D918

Q41848500-D1623609-6D5D-4707-AF06-73A58A83FA40

P2860

Q41848500-0D32BDDD-A9F0-442C-9034-7F22386FDACB

Q41848500-0E2234E3-EE9D-4F63-9C01-C8AC9F09DD42

Q41848500-10277037-9F27-43F6-9C77-778439D22BC6

Q41848500-28D9ACBC-3943-4D30-9E62-ACB2487DA70C

Q41848500-292A63CB-C846-4498-82B4-3A8A2C24C766

Q41848500-33904214-F3F7-4D4F-B351-582748C266B6

Q41848500-4579E49F-E84B-407D-BB89-14B8782BBD14

Q41848500-4851CEB9-97A2-4E05-ADC0-B63A05CB93BC

Q41848500-572FD66F-A575-430E-82DF-F0BAF9EA8C8B

Q41848500-5C6C8BB2-40DB-43B2-86D2-5C5F95A42552

P304

Q41848500-8D0497EB-9459-4C71-89F6-4880C47A9064

P31

Q41848500-8B4CB936-8C0C-4726-87F3-C43ACBA7A716

P356

Q41848500-0C12D3F8-78E4-4946-A4DD-E55D92D45015

P407

Q41848500-9A00C053-5A6A-4CBD-8FA4-CB5A43E2E438

P433

Q41848500-DC7F26A6-DE5A-4050-9FC7-E1E9C2EECCC7

P478

Q41848500-256AAE85-849B-43C6-A2DB-FBEE392DEB94

P50

Q41848500-C0AFEAE7-72EF-4434-9694-21B065EBA0D1

P577

Q41848500-A05038FE-94CD-4797-8360-F0196EC70ACE

P698

Q41848500-F6157870-86AD-401D-A708-134BACE73C44

P921

Q41848500-AD511FA2-8AFA-4B25-AC16-5089D72BFF27

Q41848500-DBE76BFF-6BAD-4BE6-92A2-D63988A58496

P932

Q41848500-F23900DB-2A7F-4976-9475-2429011C6F4F

P356

P1433

Applied and Environmental Microbiology

P1476

Use of purified Clostridium di ...... th care disinfection regimens.

@en

P2093

Claire Raisen

http://www.w3.org/2001/XMLSchema#string

Cordelia Brandt

http://www.w3.org/2001/XMLSchema#string

David Goulding

http://www.w3.org/2001/XMLSchema#string

Fiona Cooke

http://www.w3.org/2001/XMLSchema#string

Gordon Dougan

http://www.w3.org/2001/XMLSchema#string

Jennifer L Yen

http://www.w3.org/2001/XMLSchema#string

Jon Lovell

http://www.w3.org/2001/XMLSchema#string

Laura J Deakin

http://www.w3.org/2001/XMLSchema#string

Simon Clare

http://www.w3.org/2001/XMLSchema#string

Taane G Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Antiseptics and disinfectants: activity, action, and resistance

Evolutionary dynamics of Clostridium difficile over short and long time scales

Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor

Structural insights into the molecular organization of the S-layer from Clostridium difficile

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

An epidemic, toxin gene-variant strain of Clostridium difficile.

The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease.

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Innate secretory antibodies protect against natural Salmonella typhimurium infection.

P304

6895-6900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AEM.00718-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20802075

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

2953018

http://www.w3.org/2001/XMLSchema#string